Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | TACR1 | P25103 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24944476 | 0.91 | ALOX5 (0.51) | SIGMAR1ALOX5KDM4EOPRM1CYP1A2 | |
| SCHEMBL24944266 | 0.89 | OPRM1 (0.43) | SMN1; SMN2RAB9AL3MBTL1OPRM1TACR1 | |
| SCHEMBL26413844 | 0.87 | HPGD (0.41) | LMNAL3MBTL1KMT2A | |
| SCHEMBL24944048 | 0.87 | GAA (0.51) | ALOX5ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL24944477 | 0.86 | TACR1 (0.53) | SMN1; SMN2L3MBTL1SIGMAR1KMT2AALDH1A1 | |
| SCHEMBL24943732 | 0.84 | GAA (0.51) | LMNARAB9AKMT2AKDM4EALDH1A1 | |
| SCHEMBL24944263 | 0.84 | ALDH1A1 (0.44) | SMN1; SMN2SIGMAR1KMT2AALDH1A1OPRM1 | |
| SCHEMBL26478951 | 0.84 | ALDH1A1 (0.44) | LMNAL3MBTL1KMT2AKDM4EALDH1A1 | |
| SCHEMBL24944885 | 0.83 | OPRM1 (0.46) | SMN1; SMN2L3MBTL1ALDH1A1OPRM1MAPK1 | |
| SCHEMBL24943734 | 0.82 | ALDH1A1 (0.46) | SMN1; SMN2L3MBTL1ALDH1A1OPRM1TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11644753-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-09 | — | — | US | disclosed |
| US-11644753-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-09 | — | — | US | disclosed |
| US-20230021453-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11644753-B2 | Resist composition and patterning process | HNRNPU, NSUN2, HNRNPR | SMN1; SMN2 1285/4885LMNA 2930/4885RAB9A 3924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.